Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0093
+0.0001 (0.76%)
Jul 15, 2025, 3:50 PM EDT
Evofem Biosciences Employees
Evofem Biosciences had 32 employees as of December 31, 2024. The number of employees decreased by 6 or -15.79% compared to the previous year.
Employees
32
Change (1Y)
-6
Growth (1Y)
-15.79%
Revenue / Employee
$518,906
Profits / Employee
-$98,625
Market Cap
1.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
Evofem Biosciences News
- 22 days ago - Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store - PRNewsWire
- 5 weeks ago - Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors - Business Wire
- 7 weeks ago - Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1 - PRNewsWire
- 2 months ago - Evofem Biosciences GAAP EPS of $0.00, revenue of $0.85M - Seeking Alpha
- 2 months ago - Evofem Reports First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 3 months ago - Evofem Biosciences to Present at Emerging Growth Conference - PRNewsWire
- 3 months ago - Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics - PRNewsWire
- 4 months ago - Evofem Reports Fourth Consecutive Year of Net Sales Growth - PRNewsWire